|Videos|June 30, 2021
Second Opinion: CheckMate 9-ER Carcinoma Conversations
Upon its publication in the New England Journal of Medicine, the phase 3 CheckMate-9ER trial garnered significant attention across social media. Study authors Toni K. Choueiri, MD, and Robert J. Motzer, MD, discussed the significance of the trial and shed light on ongoing research in advanced RCC.
